NOMO1

Across TCGA pan-cancer cohorts, NOMO1 Mutation is linked to patient survival in 6 of 34 cancer types, making it a survival-associated NOMO1 data layer compared with 25 for mass-spec protein and 2 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher NOMO1 Mutation is associated with better overall survival. In most high-consensus cancer types, elevated NOMO1 expression acts as an unfavorable survival marker, although some lineages such as UCEC and BLCA show a favorable association.

UCEC, HNSC, and COAD are the cancer types where NOMO1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	All	1.000	0.647	.005	34	view →
HNSC	DFS	Median	III,IV	0.161	0.680	.016	24	view →
COAD	OS	Median	III,IV	0.056	0.793	<.001	24	view →
LUSC	OS	Median	All	0.350	0.677	.029	12	view →
BLCA	DFS	Median	All	0.847	0.327	.032	6	view →
SKCM	OS	Median	II,III,IV	0.581	0.848	.002	5	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

NOMO1–UCEC (OS)

Open the UCEC breakdown →